Company Beijing Kawin Technology Share-Holding Co., Ltd.

Equities

688687

CNE1000054C3

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Beijing Kawin Technology Share-Holding Co., Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-06-25 EDT			5-day change	1st Jan Change
25.61 ^CNY	-0.47%		-7.08%	-26.53%

04-10	China stocks down pressured by real estate; HK shares up	RE
04-09	Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Beijing Kawin Technology Share-Holding Co Ltd is a China-based company principally engaged in the production and sales of therapeutic drugs in the viral disease field, and the research and development of innovative drugs. The Company's recombinant human interferon Î±2b and compound glycyrrhizin drugs are applied to treat viral diseases. The Company mainly distributes its products within domestic market.

Number of employees: 584

CNY in Million	2022	Weight	2023	Weight	Delta
Chemical 50.8 %	372	32.1 %	718	50.8 %	+92.66%
Biologics 47.5 %	768	66.2 %	671	47.5 %	-12.68%
Contract Manufacture Organization/Contract Development and Manufacturing Organization 1.2 %	11	1.0 %	16	1.2 %	+45.91%
Promotional Services 0.3 %	3	0.3 %	5	0.3 %	+47.24%
Technical Services 0.1 %	0	0.0 %	1	0.1 %	+143.09%
Real Estate Leasing 0.1 %	4	0.4 %	1	0.1 %	-81.42%
Other 0.1 %	0	0.0 %	1	0.1 %	+226.64%

CNY in Million	2022	Weight	2023	Weight	Delta
China 99.9 %	1,141	100.0 %	1,387	99.9 %	+21.62%
Overseas 0.1 %	0	0.0 %	1	0.1 %	+418.04%

Managers	Title	Age	Since
De Sheng Zhou CEO	Chief Executive Officer	53	08-07-31
Wei Guo DFI	Director of Finance/CFO	38	19-10-31
Yan Cui BRD	Director/Board Member	40	11-04-30
Cheng Hao Zhu BRD	Director/Board Member	48	15-11-30
Ji Feng Shi BRD	Director/Board Member	50	16-12-31
Chong Fei He BRD	Director/Board Member	55	08-07-31
Ya Li Zhou IRC	Investor Relations Contact	30	23-04-20
Wang Haibo Edward Wang PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Jun Feng Wang BRD	Director/Board Member	50	11-06-30
Man Li Su BRD	Director/Board Member	54	21-05-11
De Sheng Zhou CEO	Chief Executive Officer	53	08-07-31
Run Lu Deng BRD	Director/Board Member	64	08-07-31
Chong Fei He BRD	Director/Board Member	55	08-07-31
Ji Feng Shi BRD	Director/Board Member	50	16-12-31
Peng Wang BRD	Director/Board Member	43	18-12-31
Chen Du BRD	Director/Board Member	64	20-03-04
Cheng Hao Zhu BRD	Director/Board Member	48	15-11-30
Yan Cui BRD	Director/Board Member	40	11-04-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	170,944,422	122,419,300 ( 71.61 %)	3,509,027 ( 2.053 %)	71.61 %

Name	Equities	%	Valuation
Zhong Geng Fund Management Co. , Ltd. 3.450 %	3,925,917	3.450 %	15 M ¥
Fullgoal Fund Management Co., Ltd. 2.475 %	2,816,593	2.475 %	11 M ¥
Golden Eagle Asset Management Co., Ltd. 1.915 %	2,179,355	1.915 %	8 M ¥
Zhong Ou Asset Management Co., Ltd 1.778 %	2,023,124	1.778 %	8 M ¥
Huatai-PineBridge Fund Management Co., Ltd. 1.697 %	1,931,001	1.697 %	7 M ¥
China Southern Asset Management Co., Ltd. 1.576 %	1,794,049	1.576 %	7 M ¥
Bosera Asset Management Co., Ltd. 1.565 %	1,780,900	1.565 %	7 M ¥
Orient Fund Management Co., Ltd. 1.402 %	1,595,827	1.402 %	6 M ¥
HuaAn Fund Management Co., Ltd. 0.8930 %	1,016,326	0.8930 %	4 M ¥
Bank of China Investment Management Co., Ltd. 0.8890 %	1,011,802	0.8890 %	4 M ¥

Beijing Kawin Technology Share-Holding Co., Ltd.

Building 3 6 Rongjing East Street

100176, Beijing

http://www.kawin.com.cn

address Beijing Kawin Technology Share-Holding Co., Ltd.(688687)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

25.61 CNY

Average target price

39.66 CNY

Spread / Average Target

+54.85%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.	-26.53%	593M
VERTEX PHARMACEUTICALS INCORPORATED	+16.49%	122B
REGENERON PHARMACEUTICALS, INC.	+21.73%	116B
ARGENX SE	+22.18%	27.03B
BIONTECH SE	-21.81%	20.36B
GENMAB A/S	-16.89%	16.43B
BEIGENE, LTD.	-18.81%	15.91B
WUXI APPTEC CO., LTD.	-44.74%	15.6B
SAREPTA THERAPEUTICS, INC.	+62.72%	14.94B
NEUROCRINE BIOSCIENCES, INC.	+3.09%	13.59B

Bio Therapeutic Drugs